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Abstract
Patient care experiences represent opportunities for establishing theories, testable hypotheses,
and data to assess the potential use of osteopathic manipulative treatment in various disease
conditions. The re-analysis of Bandeen's 1949 raw data described herein summarizes the effects of
osteopathic manipulative treatment involving pancreatic stimulatory and inhibitory techniques in
diabetic and non-diabetic patients seen over a 25-year period of clinical practice. Bandeen's data
demonstrate a reduction in blood glucose levels at 30 and 60 minutes following pancreatic
stimulation in 150 diabetic patients, and an elevation in blood glucose levels at 30 and 60 minutes
following pancreatic inhibition in 40 non-diabetic patients. Such patient-oriented research
conducted during the classic era of osteopathy in the United States provides a foundation and data
for generating hypotheses about the potential mechanisms of action of osteopathic manipulative
treatment. Osteopathic investigators would be well-served to rediscover the classic osteopathic
literature to help advance contemporary evidence-based medicine.
Rediscovering the classic osteopathic literature
The transformation from osteopathy to osteopathic med-
icine that occurred during the twentieth century in the
United States [1] increased the scope of practice and
patient care responsibilities of osteopathic physicians.
However, this evolution from a classic focus on osteo-
pathic manipulative treatment (OMT) to "full-service
healthcare" [2] may have shifted emphasis away from
patient-oriented research uniquely related to osteopathic
principles. The National Institutes of Health defines
patient-oriented research as that conducted with human
subjects (or on material of human origin such as tissues,
specimens, and cognitive phenomena) for which an
investigator directly interacts with human subjects,
including studies of mechanisms of human disease, ther-
apeutic interventions, clinical trials, and the development
of new technologies [3].
Patient care experiences represent opportunities for estab-
lishing theories, testable hypotheses, and, in some cases,
data to assess the potential use of OMT in various disease
conditions, including those not considered to be muscu-
loskeletal disorders. Two such examples of patient-ori-
ented research conducted during the classic period of
osteopathy in the United States involve OMT in stimulat-
ing immunity [4,5], and in treating pandemic influenza
[6]. In both cases, contemporary investigators have redis-
covered these classic studies in efforts to advance the oste-
opathic research agenda.
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Raw data from within-subjects observations conducted by
Castlio and Ferris-Swift during the 1930s involving the
use of splenic pump manipulation to stimulate the
immune system in persons without acute infections [4]
and in hospitalized patients [5] were recently re-analyzed
using modern statistical techniques [7,8]. Despite limita-
tions in research methodology and data collection com-
mon to the classic era, these re-analyses found that there
was some empirical basis to support the hypothesized
benefits of splenic pump manipulation in stimulating
immunity. Similarly, data gathered during the 1918–1919
pandemic [6] have bolstered osteopathic principles and
mechanistic theories in support of using OMT in patients
with influenza [9]. In fact, a comprehensive series of OMT
techniques was recently described and illustrated as
potential treatment in the event of a pandemic of avian
influenza or "bird flu" [9], although others have called for
more rigorous research, intensive planning, and coordi-
nated medical and public health responses prior to the
potential implementation of such interventions on a large
scale [10].
A new look at Bandeen's classic osteopathic 
research on diabetes mellitus
Osteopathic physicians commonly enter primary care spe-
cialties [11] and thus often have the opportunity to use
OMT in a variety of disorders, including both muscu-
loskeletal and non-musculoskeletal conditions. Diabetes
mellitus is one such disorder commonly managed by oste-
opathic physicians; however, research that addresses oste-
opathic palpatory findings or OMT in patients with
diabetes mellitus is limited. Two series of within-subjects
observations made by Bandeen in his clinical practice dur-
ing the classic era of osteopathy, however, provide some
insight into the potential benefits of OMT in comple-
menting the management of patients with diabetes melli-
tus [12].
A re-analysis of Bandeen's 1949 raw data reveals much
about the effects of pancreatic stimulatory and inhibitory
OMT techniques in patients with and without diabetes
mellitus seen over a 25-year period. The designations of
type 1 or type 2 diabetes mellitus were not in use at that
time and insulin was the mainstay of diabetes treatment.
In the first phase of Bandeen's study, fasting blood glucose
was initially measured and patients then received pancre-
atic stimulation mediated via the lateral chain ganglia in
concert with raising of the second, third, fourth, and fifth
ribs. Although Bandeen's data table suggests that both dia-
betic and non-diabetic patients were included in this
phase of the study, the lowest fasting blood glucose value
was recorded as 110 mg/dl (equivalent to fasting plasma
glucose of 126 mg/dl), thereby suggesting that all 150
patients in this phase of the study had diabetes mellitus by
contemporary standards [13]. Glucose was then measured
30 (121 patients) and/or 60 (86 patients) minutes follow-
ing pancreatic stimulation. The results indicated rapid
declines in blood glucose in the treated patients as shown
in Figure 1. In fact, a case of hypoglycemic coma was
recorded as the last observation in this series of patients!
Bandeen asserted, "...that islets of Langerhans were not
dead but were lying dormant, and relief from diabetic dis-
turbances could be obtained only by relieving the sub-
stances keeping them dormant, thereby restoring the
normal electrochemical balance of blood protein and tis-
sue colloids [12]."
In the second phase of Bandeen's study, 40 patients were
subjected to two minutes of pancreatic inhibition involv-
ing specific rotary manipulation of the eleventh and
twelfth thoracic and first lumbar vertebrae. Bandeen's
data table does not specify that blood glucose measures
were performed in a fasting state during this phase of the
study. The patients in this phase of the study were likely to
be non-diabetic based on the lower baseline (random,
non-fasting) blood glucose levels reported, and that the
hypothesized effects of pancreatic inhibition would
adversely impact blood glucose levels in diabetic patients.
Blood glucose was measured before and 30 and 60 min-
utes after pancreatic inhibition in all 40 patients. The
results indicated rapid elevations in blood glucose in the
treated patients as shown in Figure 2. Despite methodo-
logical shortcomings in reporting of the study design and
data by modern standards, and only rudimentary under-
standing of the mechanisms of diabetes mellitus, these
two phases of Bandeen's patient-oriented research pro-
vide intriguing results upon which contemporary osteo-
pathic investigators can build.
Viewing classic osteopathic research through 
the prism of contemporary medicine
Diabetes mellitus is an important public health problem.
Type 2 diabetes mellitus (T2DM) comprises 90% to 95%
of the estimated 18.2 million Americans with diabetes
mellitus [14]. The prevalence of T2DM in children and
adolescents is increasing as a consequence of the continu-
ing rise in obesity in this segment of the population [15].
Early identification of and intervention in patients with
T2DM may help control the disease process and delay its
complications, including blindness, kidney damage, and
lower-limb amputations. Such intervention may also help
control the cost of diabetes mellitus, which was estimated
to be $132 billion in the United States during 2002,
including both medical expenditures and lost productiv-
ity [16].
Normal pancreatic β-cells can adapt with a high degree of
sensitivity to changes in insulin action [17]. There exists a
hyperbolic relationship between β-cell function and insu-
lin sensitivity that continuously degrades with the transi-Osteopathic Medicine and Primary Care 2008, 2:9 http://www.om-pc.com/content/2/1/9
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tion to impaired glucose tolerance and, ultimately, to
T2DM. This phenomenon of β-cell dysfunction is a crucial
element in the pathogenesis of T2DM which has been ver-
ified in longitudinal studies of Pima Indians [18]. Thus,
over time, insulin resistance leads to hyperglycemia and
T2DM.
Factors strongly associated with insulin resistance include
obesity and physical inactivity. The cellular mechanisms
that are potentially involved in states of insulin resistance
include phosphorylation and dephosphorylation of insu-
lin receptor substrate proteins, inflammatory cytokines
released by expanded visceral adipose tissue, reduced con-
centrations of adiponectin and its insulin-sensitizing
effects in liver and muscle, classic inflammatory signaling
pathways, and defects in mitochondrial metabolism [19].
Low-grade inflammation appears to be involved in the
pathogenetic processes causing T2DM, potentially medi-
ated by tumor necrosis factor-α (TNF-α), interleukin-1β
(IL-1β), the IL-6 family of cytokines, and IL-18 [20]. In
addition to its immunoregulatory actions, IL-6 has been
proposed to affect glucose homeostasis and metabolism
directly and indirectly by action on skeletal muscle cells,
adipocytes, hepatocytes, pancreatic β-cells, and neuroen-
docrine cells [20].
Using OMT for the manifestations of T2DM may improve
the affected paraspinal tissues and the musculoskeletal
system via a generalized non-specific mechanism. Sub-
jects with diabetes mellitus are significantly more likely
than non-diabetic subjects to report daily chronic pain;
however, their elevated chronic pain risk appears to reflect
multiple anatomical locations and is not adequately
explained by diabetic neuropathy or obesity [21]. Diabe-
tes mellitus and chronic pain may have common biologi-
cal factors, such as bradykinin, IL-6, and upregulation of
kinin B1 or B2 receptors. Cytokines acting through kinin B1
and B2 receptors play a role in the pathogenesis of diabetes
mellitus as well as in inflammatory and painful processes
[21]. Osteopathic manipulative treatment has been
Mean blood glucose levels over time in diabetic patients receiving osteopathic manipulative treatment to stimulate pancreatic  functioning Figure 1
Mean blood glucose levels over time in diabetic patients receiving osteopathic manipulative treatment to stimulate pancreatic 
functioning. Baseline values are for fasting blood glucose (based on 150, 121, and 86 observations, respectively, at 0, 30, and 60 
minutes post-pancreatic stimulation).Osteopathic Medicine and Primary Care 2008, 2:9 http://www.om-pc.com/content/2/1/9
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shown to have benefits when used chronically (over 3 to
12 months) in painful low back conditions [22].
In theory, OMT may also effect disruption of a visceros-
omatic reflex arc (e.g., a pancreatic viscerosomatic reflex
arc) thereby creating the potential for amelioration of the
underlying T2DM disease process through a specific
mechanism [23]. However, clinical studies to support this
theoretical concept are sparse. An important barrier here-
tofore has been that viscerosomatic reflexes of T2DM have
not been empirically demonstrated, but have been based
on osteopathic principles. Historically, diabetes mellitus
has been viewed as a pancreatic disease, with pancreatic
viscerosomatic reflexes expected at the T5-T11 spinal seg-
mental levels [23]. Nevertheless, Bandeen's pancreatic
stimulatory OMT technique in diabetic patients may rep-
resent a specific OMT technique for treating a pancreatic
viscerosomatic reflex arc. In retrospect, Bandeen's specific
treatment may have augmented functioning of the pan-
creatic β-cells by mimicking modern-day drug therapy,
potentially via one or more of the following mechanisms:
acute stimulation of insulin release, stimulation of insulin
biosynthesis, inhibition of β-cell apoptosis, or stimula-
tion of β-cell differentiation [19]. Bandeen also com-
mented on the recuperative power and lasting qualities of
pancreatic stimulation, indicating that dramatic improve-
ment in diabetic control could be accomplished within
one month and could last up to 15 years in his clinical
experience [12].
More recently, a case-control study of osteopathic palpa-
tory findings in T2DM reported significant tissue texture
changes at the T11-L2 spinal segmental levels that were
suggestive of a renal viscerosomatic reflex arc, and indica-
tive of diabetic nephropathy based on the kidney's auto-
nomic nervous system supply [23]. The argument for
causality between underlying renal pathology and the pal-
pated tissue texture changes at T11-L2 was further
strengthened by augmented renal viscerosomatic reflex
responses observed in T2DM subjects with longer dura-
Mean blood glucose levels over time in non-diabetic patients receiving osteopathic manipulative treatment to inhibit pancreatic  functioning Figure 2
Mean blood glucose levels over time in non-diabetic patients receiving osteopathic manipulative treatment to inhibit pancreatic 
functioning. Baseline values are for random (non-fasting) blood glucose (based on 40 observations each at 0, 30, and 60 minutes 
post-pancreatic inhibition).Osteopathic Medicine and Primary Care 2008, 2:9 http://www.om-pc.com/content/2/1/9
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tions of disease (>5 years) and comorbid hypertension.
Thus, specific renal stimulatory OMT techniques aimed at
the T11-L2 spinal segmental levels may effect disruption
of a renal viscerosomatic reflex arc, thereby preventing or
delaying the occurrence of diabetic nephropathy in
patients with T2DM.
In the current environment that promotes translational
research, exciting discoveries involving OMT are being
made at several levels. The immediate effects of abdomi-
nal lymphatic pump treatment on lymph flow and leuko-
cyte output have been measured using a dog model [24].
Lymphatic pump treatment increased leukocyte counts
and lymph flow 2- and 4-fold, respectively, thereby
increasing leukocyte flux 8-fold. Enhanced mobilization
and lymphatic transport of leukocytes is likely an impor-
tant mechanism of increased immunity based on these
findings. Also, using a dog model, osteopathic palpatory
techniques have successfully identified left-sided paraspi-
nal changes at the T2-T5 spinal segmental levels indicative
of a viscerosomatic reflex arc attributed to myocardial
ischemia [25].
An in vitro model involving human fibroblasts has been
developed to simulate and study the effects of indirect
OMT techniques on repetitive motion strain [26].
Whereas modeled repetitive motion strain caused a reduc-
tion in fibroblast proliferation and a delayed inflamma-
tory response, modeled indirect OMT techniques reversed
the inflammatory effects in cells that had been strained
repetitively. These findings suggest that fibroblast prolifer-
ation and expression and secretion of proinflammatory
and anti-inflammatory ILs may contribute to the efficacy
of indirect OMT techniques. In another study, human
subjects with chronic low back pain had significantly
reduced levels of 5-hydroxyindoleacetic acid (a serotonin
metabolite) at 30 minutes post-OMT and serotonin at 24
hours post-OMT when compared with baseline concen-
trations [27].
Conclusion
Patient-oriented research conducted during the classic era
of osteopathy in the United States provides a foundation
and, in some cases, useful data for generating hypotheses
about the potential mechanisms of action of OMT. Oste-
opathic investigators would be well-served to rediscover
the classic osteopathic literature in their quest to help
advance evidence-based medicine.
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